, ,

1)Liu et al.: An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies

2)Yahi et al.: Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?

3)Van Egeren et al.: “Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein

4)Lempp et al.: Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies

5)Asarnow et al.: Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia

6)Martin et al.: The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages

7)Hoffmann et al.: The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

8)Kimura et al.: Virological characteristics of the novel SARS-CoV-2 Omicron variants including BA.2.12.1, BA.4 and BA.5

[All references pilfered from Dr. Paul Alexander‘s “Substack Alexander COVID News evidence-based medicine:” HERE]